Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11746077 | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Charles R. Holst, Angela Minnella, Paul Mollard, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2023-09-05 |
| 11680034 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | Steven Richards | 2023-06-20 |
| 11667596 | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Charles R. Holst, Angela Minnella, Paul Mollard, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2023-06-06 |
| 11312697 | Process for the production of alpha-tocotrienol and derivatives | Kieron E. Wesson, Orion D. Jankowski | 2022-04-26 |
| 11174212 | 2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Charles R. Holst, Angela Minnella, Paul Mollard, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2021-11-16 |
| 10981855 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | Steven Richards | 2021-04-20 |
| 10703701 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | Steven Richards | 2020-07-07 |
| 10470986 | Resorcinol compounds for dermatological use | Dana Davis, Viktoria Kheifets | 2019-11-12 |
| 10189830 | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders | Kieron E. Wesson, Christopher R. Cornell | 2019-01-29 |
| 10071978 | Process for the production of alpha-tocotrienol and derivatives | Kieron W. Wesson, Orion D. Jankowski | 2018-09-11 |
| 9868711 | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders | Dana Davis, William D. Shrader | 2018-01-16 |
| 9670170 | Resorufin derivatives for treatment of oxidative stress disorders | Dana Davis, William D. Shrader | 2017-06-06 |
| 9629815 | Benzoquinone derivatives for treating oxidative stress disorders | William D. Shrader, Viktoria Kheifets | 2017-04-25 |
| 9486435 | (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases | Kieron E. Wesson | 2016-11-08 |
| 9296712 | Resorufin derivatives for treatment of oxidative stress disorders | Dana Davis, William D. Shrader | 2016-03-29 |
| 9090576 | 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases | Kieron E. Wesson, Orion D. Jankowski, William D. Shrader, Edgar P. LEE | 2015-07-28 |
| 9073873 | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases | Orion D. Jankowski, Kieron E. Wesson | 2015-07-07 |
| 8952071 | (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases | Kieron E. Wesson | 2015-02-10 |
| 8716527 | 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases | Kieron E. Wesson, Orion D. Jankowski, Paul Mollard, William D. Shrader, Christopher R. Cornell | 2014-05-06 |
| 8716486 | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases | Orion D. Jankowski, Kieron E. Wesson | 2014-05-06 |
| 8575369 | Process for the production of alpha-tocotrienol and derivatives | Kieron E. Wesson, Orion D. Jankowski | 2013-11-05 |
| 8106223 | Process for the production of alpha-tocotrienol and derivatives | Kieron E. Wesson, Orion D. Jankowski | 2012-01-31 |